Roche Holding AG’s Herceptin

Roche Holding AG’s Herceptin

Shortages of injectable cancer drugs such as Roche Holding AG’s Herceptin for breast tumors have created an opening for dangerous unapproved versions to be sold to clinics and other health-care providers, the FDA said last month. Photo: Jeff J Mitchell/Getty Images